Universidad de La Laguna-ko ikertzaileekin lankidetzan egindako argitalpenak (20)

2024

  1. Multicenter Long-Term Real World Data on Treatment With Lumasiran in Patients With Primary Hyperoxaluria Type 1

    Kidney International Reports, Vol. 9, Núm. 1, pp. 114-133

2023

  1. Comprehensive approach to people with type 2 diabetes. Diabetes Knowledge Area of the Spanish Society of Endocrinology and Nutrition

    Endocrinologia, Diabetes y Nutricion, Vol. 70, pp. 95-102

  2. Genotypic variability in patients with clinical diagnosis of Bartter syndrome type 3

    Scientific reports, Vol. 13, Núm. 1, pp. 12587

  3. Post-transplant diabetes mellitus and renal cell cancer after renal transplantation

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 38, Núm. 6, pp. 1552-1559

2022

  1. Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients

    Frontiers in Medicine, Vol. 9

  2. Prevalence of gout in the adult general population in Spain: Estimating the proportion of undiagnosed cases

    Joint Bone Spine, Vol. 89, Núm. 1

  3. Prevalence of symptomatic axial osteoarthritis phenotypes in Spain and associated socio-demographic, anthropometric, and lifestyle variables

    Rheumatology International, Vol. 42, Núm. 6, pp. 1085-1096

  4. Prévalence de la goutte dans la population générale en Espagne : une estimation du taux de cas non diagnostiqués

    Revue du Rhumatisme (Edition Francaise), Vol. 89, Núm. 4, pp. 389-395

2021

  1. Lung Transplant Improves Survival and Quality of Life Regardless of Telomere Dysfunction

    Frontiers in Medicine, Vol. 8

  2. Prevalence of symptomatic osteoarthritis in Spain: EPISER2016 study

    Reumatologia Clinica, Vol. 17, Núm. 8, pp. 461-470

2020

  1. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  2. Fracture risk assessment in the general population in Spain by FRAX® algorithm. EPISER2016 study

    Medicina Clinica, Vol. 154, Núm. 5, pp. 163-170

  3. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  4. Prevalence of systemic lupus erythematosus in Spain: Higher than previously reported in other countries?

    Rheumatology (United Kingdom), Vol. 59, Núm. 9, pp. 2556-2562

2019

  1. Platelet-rich plasma for the treatment of diabetic foot ulcers: A meta-analysis

    Wound Repair and Regeneration, Vol. 27, Núm. 2, pp. 170-182

  2. Prevalence of rheumatic diseases in adult population in Spain (EPISER 2016 study): Aims and methodology

    Reumatologia Clinica, Vol. 15, Núm. 2, pp. 90-96

2016

  1. Perfil neuropsicológico en el síndrome opsoclono-mioclonoataxia como forma de presentación de tumores neuroblásticos

    Revista de Neurologia, Vol. 62, Núm. 6, pp. 249-257

2015

  1. Differential effect of modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for symptoms evaluation within the new GOLD staging and mortality in COPD

    Chest, Vol. 148, Núm. 1, pp. 159-168

2014

  1. The Interplay between natural selection and susceptibility to melanoma on allele 374F of SLC45A2 gene in a south European population

    PLoS ONE, Vol. 9, Núm. 8

2008

  1. Factors influencing pregnancy outcome in women with type 2 versus type 1 diabetes mellitus

    Acta Obstetricia et Gynecologica Scandinavica, Vol. 87, Núm. 1, pp. 43-49